openPR Logo
Press release

Transformative Trends Impacting the Advanced Therapeutics Pharmaceutical Outsourcing Market Landscape: Strategic Partnerships In Advanced Therapeutics Pharmaceutical Outsourcing

09-15-2025 09:36 AM CET | Health & Medicine

Press release from: The Business Research Company

Advanced Therapeutics Pharmaceutical Outsourcing

Advanced Therapeutics Pharmaceutical Outsourcing

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Advanced Therapeutics Pharmaceutical Outsourcing Market Size By 2025?
The size of the advanced therapeutics pharmaceutical outsourcing market has experienced consistent growth in previous years. It is anticipated to increase from $8.07 billion in 2024 to $8.41 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.2%. The expansion during the historical period is largely due to the development of the biopharmaceutical infrastructure, regulatory compliance, rising demand for innovative drugs to address chronic and severe illnesses, enhanced efficiency, and an increasing need for customised medicine.

How Big Is the Advanced Therapeutics Pharmaceutical Outsourcing Market Size Expected to Grow by 2029?
The market size of advanced therapeutics pharmaceutical outsourcing is predicted to witness consistent expansion in the upcoming years. It is projected to rise to "$10.21 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. The predicted growth during the forecast period can be linked to the growing use of cell and gene therapies and a heightened focus on mRNA therapies. There's also an increasing demand for advanced treatments and the provision of efficient, cost-saving solutions by outsourcing partners, and collective innovation. Some major trends expected during this forecast period include technological sophistication, an increase in expertise in advanced therapeutic treatments, a surge in the innovative therapy pipeline, the incorporation of state-of-the-art technology, as well as swift progress in gene therapy, cell therapy, and mRNA technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report

Which Key Market Drivers Powering Advanced Therapeutics Pharmaceutical Outsourcing Market Expansion and Growth?
The surge in the utilization of cell and gene therapies is predicted to energize the expansion of the advanced therapeutics pharmaceutical outsourcing market. These therapies represent groundbreaking treatments and leverage living cells or genetic substances to treat or eradicate diseases. Outsourcing in the realm of advanced therapeutics pharmaceuticals is employed in cell and gene therapies which provide connections to service providers known for their achievements and highly skilled workforce, thus freeing companies the effort and resources required to assemble their teams. A November 2023 report from the UK-based scientific journal, Nature, showed that the number of new patients benefiting from gene therapies is projected to rise from 16,244 in 2020 to 94,696 in 2025. Consequently, the escalating adoption of cell and gene therapies is fueling the growth of the advanced therapeutics pharmaceutical outsourcing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp

What Trends Will Shape the Advanced Therapeutics Pharmaceutical Outsourcing Market Through 2029 and Beyond?
Leading firms in the advanced therapeutics pharmaceutical outsourcing market are emphasizing on strategic collaborations to offer dependable services to their clientele. Such partnerships are cooperative agreements between two or more parties, usually businesses, designed to attain shared objectives that couldn't be achieved solely. A case in point is Lonza, a Swiss pharmaceutical, biotechnology, and nutrition manufacturing enterprise, which formed a partnership with Context Therapeutics Inc., an American biopharmaceutical firm working on developing medications for solid tumors, in January 2023. In this collaboration, Lonza is responsible for the evaluation of manufacturability, creation of gene and cell line, and procedure development for both the drug substance and product.

What Are the Emerging Segments in the Advanced Therapeutics Pharmaceutical Outsourcing Market?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented -

1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging

Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13768&type=smp

Who Are the Global Leaders in the Advanced Therapeutics Pharmaceutical Outsourcing Market?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market report are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Croda International Plc, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, Marken, AGC Biologics, Evotec SE, ProPharma Group, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cryoport Systems Inc., Cytovance Biologics

Which are the Top Profitable Regional Markets for the Advanced Therapeutics Pharmaceutical Outsourcing Industry?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2024. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13768

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transformative Trends Impacting the Advanced Therapeutics Pharmaceutical Outsourcing Market Landscape: Strategic Partnerships In Advanced Therapeutics Pharmaceutical Outsourcing here

News-ID: 4182380 • Views:

More Releases from The Business Research Company

2025-2034 Anti-Inflammatory Therapeutics Market Roadmap: Insights for Competitive Advantage
2025-2034 Anti-Inflammatory Therapeutics Market Roadmap: Insights for Competitiv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Anti-Inflammatory Therapeutics Market Size By 2025? In the past few years, the market size of anti-inflammatory therapeutics has seen a consistent increase. It is projected to rise from $114.71 billion in 2024 to $117.28 billion in 2025, marking a compound annual growth rate (CAGR) of
Inhalation CDMO Industry Outlook 2025-2029: Market Set to Cross $2.84 Billion Milestone
Inhalation CDMO Industry Outlook 2025-2029: Market Set to Cross $2.84 Billion Mi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Inhalation CDMO Market Size By 2025? In recent times, the market size of the inhalation CDMO has shown considerable growth. The market, valued at $2.08 billion in 2024, is projected to increase to $2.2 billion in 2025, with a Compound Annual Growth Rate (CAGR) of
Key Trends Reshaping the Fentanyl Market: Increasing Focus On Product Approvals To Gain The Revenues Industry Transformation
Key Trends Reshaping the Fentanyl Market: Increasing Focus On Product Approvals …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Fentanyl Market Size Growth Forecast: What to Expect by 2025? Over the past few years, the fentanyl market has experienced robust growth. It is projected to increase from $16.22 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. The historic growth
Rising Skin Disease Prevalence Fueling Growth In Complicated Skin And Skin Structure Infections Drugs Market: A Key Catalyst Accelerating Complicated Skin And Skin Structure Infections Drugs Market Growth in 2025
Rising Skin Disease Prevalence Fueling Growth In Complicated Skin And Skin Struc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Complicated Skin And Skin Structure Infections Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of drugs for complex skin and skin structure infections has seen robust growth. The market value will rise from $9.51 billion in 2024 to

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the